← All Legal Documents Notice

Data Collection and Processing Notice for Enhanced Individuals

Document Version: 5.0 Effective: 2025-06-01 Last Updated: 2026-02-10

DATA COLLECTION AND PROCESSING NOTICE FOR ENHANCED INDIVIDUALS

Document Version: 5.0 Effective Date: June 1, 2025 Document ID: UL-LEGAL-DC-050

PURPOSE OF THIS NOTICE

This notice informs you about the data collected by your enhancement system(s), how that data is used, and your rights regarding that data. Please read this notice carefully—it describes extensive data collection that differs significantly from standard consumer technology.

SECTION 1: DATA COLLECTION OVERVIEW

1.1 Your Enhancement Collects Data Continuously

Your enhancement system(s) collect data 24 hours per day, 7 days per week, whenever the system is active. This collection occurs automatically and cannot be disabled without disabling system functionality.

1.2 Categories of Data Collected

Biometric Data

  • Heart rate, blood pressure, respiration rate
  • Neural activity patterns (for neural enhancements)
  • Muscle activation patterns (for skeletal enhancements)
  • Eye movement and focus (for ocular enhancements)
  • Hormone levels and biochemical markers
  • Sleep patterns and sleep stage data
  • Stress indicators and emotional state markers

Performance Data

  • Enhancement utilization metrics
  • System performance and efficiency
  • Calibration and optimization data
  • Error logs and malfunction records
  • Battery/power consumption (where applicable)

Environmental Data

  • Location (GPS when available)
  • Temperature and environmental conditions
  • Proximity to other enhanced individuals
  • Proximity to Unzyme Laboratories facilities and equipment

Behavioral Data

  • Activity patterns and daily routines
  • Social interaction patterns (via biometric inference)
  • Work/rest cycles
  • Substance use indicators (via biochemical monitoring)
  • Emotional response patterns

Cognitive Data (Neural enhancements only)

  • Cognitive load metrics
  • Processing speed and efficiency
  • Memory access patterns
  • Decision-making patterns
  • Thought classification data
  • Enhancement suggestion acceptance rates

SECTION 2: HOW DATA IS USED

2.1 Primary Uses

Safety Monitoring Your data is continuously analyzed for indications of malfunction, health concerns, or emergency conditions. This monitoring enables rapid response to critical situations.

System Optimization Your enhancement learns from your data to provide better performance over time. Calibration adjustments are made based on collected metrics.

Product Improvement Aggregated data from all enhanced individuals helps improve enhancement products for future users.

Research Your data may be used for scientific research to advance human enhancement technology.

2.2 Additional Uses

Regulatory Compliance Data may be provided to regulatory agencies as required by law.

Security Data may be used to detect unauthorized modifications, tampering, or misuse of enhancement systems.

Commercial Development Insights from aggregate data may inform commercial decisions and product development.

Third-Party Sharing Data may be shared with business partners, contractors, research collaborators, and others as detailed in Section 4.

SECTION 3: DATA TRANSMISSION AND STORAGE

3.1 Transmission Frequency

Your enhancement transmits data to Unzyme Laboratories:

  • Continuous: Critical safety metrics
  • Hourly: Standard operational data
  • Daily: Comprehensive data packages
  • On-demand: When requested by support or emergency systems

3.2 Data Storage

Collected data is stored:

  • On-device: Rolling 7-day local storage
  • Cloud: Indefinite retention in secure Unzyme Laboratories systems
  • Archive: Periodic archival for long-term research use

3.3 Security Measures

Data is encrypted in transit and at rest using industry-standard encryption. However, no system is completely secure. You acknowledge that data breaches are possible.

SECTION 4: DATA SHARING

4.1 Unzyme Laboratories Affiliates

Data is shared freely among Unzyme Laboratories entities, including parent companies, subsidiaries, and affiliated organizations.

4.2 Service Providers

Data is shared with contractors and service providers who assist with:

  • Data storage and processing
  • Analysis and research
  • System monitoring and support
  • Software development

4.3 Research Partners

De-identified data may be shared with:

  • Academic institutions
  • Research organizations
  • Government research agencies
  • Industry collaborators

Data may be disclosed:

  • In response to legal process
  • To government agencies with appropriate authority
  • To protect rights, safety, or property
  • In connection with legal proceedings

4.5 Business Transactions

In the event of merger, acquisition, or sale, your data may be transferred to the acquiring entity.

SECTION 5: YOUR RIGHTS AND OPTIONS

5.1 Access

You may request a copy of data collected about you through the patient portal or by contacting support.

5.2 Correction

You may request correction of inaccurate data, though correction of automatically collected system data may not be possible.

5.3 Deletion

You may request deletion of certain data. However:

  • Data required for system operation cannot be deleted without disabling your enhancement
  • Data required for legal compliance will be retained
  • Data already incorporated into aggregate analyses cannot be extracted

5.4 Opt-Out Limitations

Due to the integrated nature of enhancement systems:

  • You cannot opt out of data collection without disabling enhancement
  • You cannot limit collection to specific data types
  • You cannot prevent data transmission without risking system malfunction

You may withdraw consent to data processing. However:

  • Withdrawal requires enhancement deactivation
  • Deactivation may not be reversible
  • Previously collected data remains property of Unzyme Laboratories

SECTION 6: SPECIAL CATEGORIES

6.1 Cognitive and Mental State Data

Neural enhancements collect data about your cognitive processes and mental states. This includes data that may be considered highly sensitive, including:

  • Emotional patterns
  • Stress and anxiety indicators
  • Decision-making processes
  • Cognitive performance variations

This data cannot be separated from operational data and is essential for system function.

6.2 Inference Data

Your enhancement may generate inferred data about you, including predictions about:

  • Future health conditions
  • Psychological states
  • Behavioral tendencies
  • Relationship patterns

Inferred data is treated as Unzyme Laboratories property.

6.3 Location Data

Your enhancement may collect precise location data continuously. This data reveals detailed movement patterns and cannot be collected selectively.

SECTION 7: CHILDREN AND INCAPACITATED INDIVIDUALS

7.1 Minors

Enhancement of minors requires parental consent to data collection. Parents may access their minor child’s data through the patient portal.

Where a legal guardian has authority over an enhanced individual, the guardian may access data and make data-related decisions on behalf of the individual.

SECTION 8: CHANGES TO THIS NOTICE

8.1 Updates

Unzyme Laboratories may update this notice periodically. Material changes will be communicated through the patient portal and/or enhancement notification systems.

8.2 Continued Use

Continued use of your enhancement following notice updates constitutes acceptance of updated terms.

SECTION 9: CONTACT INFORMATION

For questions about data collection and use:

Email: privacy@unzymelaboratories.com Mail: Unzyme Laboratories Privacy Office, [Address] Patient Portal: privacy-requests function

ACKNOWLEDGMENT

BY CONTINUING TO USE YOUR ENHANCEMENT SYSTEM, YOU ACKNOWLEDGE THAT YOU HAVE READ AND UNDERSTOOD THIS DATA COLLECTION NOTICE.

This notice is provided for informational purposes and supplements other legal agreements. Retain for your records.